Nathan M Shaw1, Nizar Hakam1, Jason L Lui1, Behnam Nabavizadeh1, Kevin D Li1, Patrick Low1, Behzad Abbasi1, Benjamin N Breyer2,3. 1. Department of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. 2. Department of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. Benjamin.Breyer@ucsf.edu. 3. Department of Epidemiology and Biostatistics, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. Benjamin.Breyer@ucsf.edu.
Abstract
PURPOSE: To evaluate the rate of perioperative venous thromboembolism (VTE) among patients undergoing common benign urologic reconstructive cases. We hypothesize that this rate will be lower than previously described. METHODS: We utilized the American College of Surgeons National Surgical Quality Improvement Project database from 2015 to 2019 to evaluate 30-day perioperative risk of VTE. Patients ≥ 18 years old undergoing benign urologic reconstructive cases were selected using Current Procedural Terminology (CPT) codes. Demographic, comorbidity, and operative variables were captured. The primary outcome was VTE within the 30-day postoperative period. RESULTS: We identified 8467 patients who met inclusion criteria. The majority of patients were male (> 95%) with an average age of 65 and BMI of 29.6. There were 23 VTE events (0.27%) within the 30-day perioperative period. Fourteen (14/59) procedures had a perioperative VTE. Many of the traditional factors for VTE including operative time and obesity significantly increased risk of VTE in univariate analysis. In multivariate analysis, only BMI (OR 1.09; 95% CI 1.01-1.12) and inpatient status (OR 4.42; 95% CI 1.9-10.2) were correlated with increased perioperative VTE. CONCLUSION: The rate of VTE among patients undergoing benign urologic reconstructive cases is low. Providers should continue to have high index of suspicion particularly for inpatients with high BMI in addition to other known risk factors for VTE.
PURPOSE: To evaluate the rate of perioperative venous thromboembolism (VTE) among patients undergoing common benign urologic reconstructive cases. We hypothesize that this rate will be lower than previously described. METHODS: We utilized the American College of Surgeons National Surgical Quality Improvement Project database from 2015 to 2019 to evaluate 30-day perioperative risk of VTE. Patients ≥ 18 years old undergoing benign urologic reconstructive cases were selected using Current Procedural Terminology (CPT) codes. Demographic, comorbidity, and operative variables were captured. The primary outcome was VTE within the 30-day postoperative period. RESULTS: We identified 8467 patients who met inclusion criteria. The majority of patients were male (> 95%) with an average age of 65 and BMI of 29.6. There were 23 VTE events (0.27%) within the 30-day perioperative period. Fourteen (14/59) procedures had a perioperative VTE. Many of the traditional factors for VTE including operative time and obesity significantly increased risk of VTE in univariate analysis. In multivariate analysis, only BMI (OR 1.09; 95% CI 1.01-1.12) and inpatient status (OR 4.42; 95% CI 1.9-10.2) were correlated with increased perioperative VTE. CONCLUSION: The rate of VTE among patients undergoing benign urologic reconstructive cases is low. Providers should continue to have high index of suspicion particularly for inpatients with high BMI in addition to other known risk factors for VTE.
Authors: Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: Epidemiology Date: 2007-11 Impact factor: 4.822
Authors: Jin K Kim; Mark Jason De Jesus; Min Joon Lee; Joana Dos Santos; Jun S Dy; Jessica M Ming; Mandy Rickard; Armando J Lorenzo; Michael E Chua Journal: J Urol Date: 2021-12-01 Impact factor: 7.600
Authors: Christina M Escobar; Alejandro Gomez-Viso; Surbhi Agrawal; Scott Smilen; Nirit Rosenblum; Benjamin M Brucker; Dominique Malacarne Pape Journal: Neurourol Urodyn Date: 2020-10-14 Impact factor: 2.696
Authors: Nathaniel R Smilowitz; Navdeep Gupta; Yu Guo; Thomas S Maldonado; John W Eikelboom; Samuel Z Goldhaber; Sripal Bangalore; Jeffrey S Berger Journal: TH Open Date: 2017-07
Authors: Behzad Abbasi; Nathan M Shaw; Jason L Lui; Kevin D Li; Architha Sudhakar; Patrick Low; Nizar Hakam; Behnam Nabavizadeh; Benjamin N Breyer Journal: World J Urol Date: 2022-08-26 Impact factor: 3.661